Zynerba Pharmaceuticals Inc. (ZYNE) surged 15.21% or 1.39 to $10.53. It is nearly 1.08 million shares traded, which is 350.93% compare to the average total volume 308202. The market cap of ZYNE is $142.72 million. The year to date change is -29.67%. The 52 week price range is from $5.42 to $25.95. Price of ZYNE have changed -5.38% during last week. It have changed -19.61% over last month, -19.82% over last 3 months, 47.42% over last 6 months and -55.99% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 11.31. It is 7.41% above current price. The 200-day Moving Averages for ZYNE is 12.07. It is 14.62% above current price. The 52-week High is 25.95. It is 146.44% from the current price. The 52-week Low is 5.42. It is -48.53% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 8.29 on 2018-02-15. Short % to float is 20.81%. There are some statistics of ZYNE. It is has market cap $142.72 million. The share outstanding is 13.55 million. The average volume is 308202. The percent of top 15 Institution holding is 11.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -64.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -56.31%.